The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain.
Liepe
Knut
K
Department of Nuclear Medicine, University Hospital Dresden, Fetscherstrasse 74, 01307, Dresden, Germany. liepe@rcs.urz.tu-dresden.de
Runge
Roswitha
R
Kotzerke
Jörg
J
D000368:Aged; D000369:Aged, 80 and over; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology; D012968:Etidronic Acid / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017567:Karnofsky Performance Status; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology* / Q000517:prevention & control; D010166:Palliative Care / Q000379:methods; D011471:Prostatic Neoplasms / Q000473:pathology; D011868:Radioisotopes / Q000627:therapeutic use; D011795:Surveys and Questionnaires; D013997:Time Factors; D016896:Treatment Outcome
D018712:Analgesics, Non-Narcotic; D009942:Organometallic Compounds; D009943:Organophosphorus Compounds; D011868:Radioisotopes; C101598:rhenium-186 HEDP; C061972:samarium Sm-153 lexidronam; D012968:Etidronic Acid